Skip to content
+49 (0) 3302 20 94 49 - 0Neuendorfstraße 23 b/d 16761 Hennigsdorf (Germany)info@pentracor.de
Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new window
Pentracor
PentracorPentracor
  • Home
  • Therapy
    • CRP apheresis
    • CRP adsorber
    • Range of Applications
    • Applying Centers
    • Specialist Information
    • Publications
  • Services
  • About us
    • About us
    • Career
    • Medical Advisory Board
    • Partners
    • Investors
    • Funding projects
  • Investor Relations
    • Investor Relations
    • Bond
    • Financial Publications
    • Financial Releases
    • Questions & Answers
  • News
    • News
    • Press Releases
    • Published Papers
    • Awards
    • Webinars
    • Events
    • Other
  • Contact
Book a visit
  • Home
  • Therapy
    • CRP apheresis
    • CRP adsorber
    • Range of Applications
    • Applying Centers
    • Specialist Information
    • Publications
  • Services
  • About us
    • About us
    • Career
    • Medical Advisory Board
    • Partners
    • Investors
    • Funding projects
  • Investor Relations
    • Investor Relations
    • Bond
    • Financial Publications
    • Financial Releases
    • Questions & Answers
  • News
    • News
    • Press Releases
    • Published Papers
    • Awards
    • Webinars
    • Events
    • Other
  • Contact

Archives: News

You are here:
  1. Home
  2. news

Poster prize at 84th Annual Meeting of DGK

By Pentracor10. March 2019

07.04.2018

The poster "Selective CRP apheresis as a new treatment option in acute myocardial infarction (CAMI1 study)" by Prof. Dr. Christoph Garlichs was awarded a poster prize at the 84th Annual Meeting of the DGK.

First case report about PentraSorb® CRP published

By Pentracor6. November 2018

06.11.2018
The article describes for the first time the treatment of a patient after an acute myocardial infarction (STEMI) with the PentraSorb® CRP. The patient was treated twice with immunapheresis and tolerated the treatment without side effects. The CRP concentration could be reduced by approx. 45%.

1
234
…56789
Go to Top
en_GB
en_GB de_DE